English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17939/22958 (78%)
Visitors : 7387462      Online Users : 101
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/20651


    Title: Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
    Authors: Chien, Y.-L.
    Hwu, H.-G.
    Hwang, T.-J.
    Hsieh, M.H.
    Liu, C.-C.
    Lin-Shiau, S.-Y.
    Liu, C.-M.
    Keywords: Lipid peroxidation;Nitric oxide;Oxidative stress;Schizophrenia;Superoxide dismutase;Symptoms
    Date: 2020-04
    Issue Date: 2020-03-25T04:20:33Z (UTC)
    Publisher: Progress in Neuro-Psychopharmacology and Biological Psychiatry
    ISSN: 0278-5846
    Abstract: Several studies have suggested a higher oxidative stress in schizophrenia. However, the implications of oxidative stress on clinical symptoms remain unclear. This study aimed to investigate the platelet oxidative stress in different stages of schizophrenia (i.e., chronic stable and acute relapse) in order to clarify the clinical implications of oxidative stress and the treatment effects. We recruited 43 chronic stable patients with schizophrenia and 48 non-psychiatric controls. Platelets were collected for measuring the levels of nitric oxide (NO), lipid peroxidation (LPO), and glutathione (GSH) and the activity of GSH peroxidase (GPx) and superoxide dismutase (SOD). The levels and activity were compared between patients and controls and were examined for their relationship with clinical severity. Further, we evaluated the changes of levels and activity before and after treatment in an independent sample with acute relapse (N = 19). Patients with chronic stable schizophrenia had lower SOD activity compared to non-psychiatric controls. In chronic stable patients, NO level was positively correlated with positive and disorganized symptoms, while the GPx activity were negatively correlated with excitement. In patients with acute relapse, the levels and activity were not different before and after four weeks of antipsychotic treatment, but LPO level was negatively correlated with pretreatment disorganized symptoms. The change of LPO can also predict the change of disorganized symptoms and negative symptoms. Our findings suggest that platelet SOD was lower in chronic stable schizophrenia. Platelet LPO may be associated with less disorganized symptoms in acute relapse patients and better treatment response. © 2020
    URI: https://ir.csmu.edu.tw:8080/ir/handle/310902500/20651
    Relation: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 99, no.109868
    Appears in Collections:[口腔醫學研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    Clinical-implications-of-oxidative-stress-in-schizophrenia-Acute-relapse-and-chronic-stable-phase2020Progress-in-NeuroPsychopharmacology-and-Biological-Psychiatry.pdf330KbAdobe PDF151View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback